Skip to content
Skin Cancer Facts and StatisticsLearn More

Learn about the latest skin cancer statistics,
and the latest advancements in research.

2026 Skin Cancer Facts and Statistics

7 Questions to Ask When Choosing a CRO for Your Clinical TrialLearn More

Choosing the right CRO is an important decision that will set your trial up for success.
Explore seven questions and considerations to aid in your decision making.

7 Questions to Ask When Choosing a CRO for Your Clinical Trial

Rare Disease Research UpdatesLearn More

Rare disease research has great potential for clinical advancement,
and may help improve our understanding of other diseases.

Rare Disease Research Updates

Parkinson's DiseaseLearn More

With knowledge of the disease growing each year, investment in research
has accelerated, offering hope to people living with challenging symptoms.

New Developments in Parkinson’s Disease Research

Criterium

Thank you to all of our partners, colleagues and sponsors
who continue to make Criterium a success!

Providing Clinical Trial Innovation & Excellence for more than 30 years

Clinical Research Updates in Traumatic Brain Injury (TBI)Learn More

New research, diagnostics, and treatments are offering hope to
people living with the long-term effects of TBI

Clinical Research Updates in Traumatic Brain Injury

Learn More

Explore new minimally-invasive interventions, AI-ECG models & more

New Advances in Cardiovascular Disease Research and Treatment

Learn More

Advancing personalized medicine and improved accessibility of care

Clinical Trials and Research to Watch in 2026

Advancements in Lung Cancer ResearchLearn More

Discover the latest advancements in diagnostics and treatments.

Recent Advances in Lung Cancer Research

Learn More

Learn about the latest advancements in breast cancer research.

Breast Cancer Research Updates

Clinical Trial Services - Criterium - Global CROLearn More

Learn how IRT and remote monitoring keep trials running smoothly

Criterium Technology ensures that research never stops

Criterium - Clinical Trials - CRO

Get To Know Us!

We are the Premier Hands-on CRO

Therapeutic Areas - Clinical Trial CRO - Criterium

Get To Know Us!

We are the Premier Hands-on CRO

Criterium Global CRO - Clinical Trial Services, Clinical Research

Get To Know Us!

We are the Premier Hands-on CRO

Innovative Clinical Research Solutions

- Since 1991 -

Full-Service, Dedicated, Data Driven – from “Thought to Finish”, Every Trial, Every Time.

Our Competitive Edge

Consider it Done!

Clinical Trial Services - Criterium - Clinical Trials - CRO

Clinical Trial Services

High level of expertise & high-value technology for every trial

Core Science Solutions - Criterium - Clinical Trials - CRO

CORE Science Solutions

Our Unique Centralized Network Model (CNM) for Translational Research

Technology - Criterium - Clinical Trials - CRO

Criterium Technology

Clinical Development tailored to each client’s needs

IVR IWR ePRO - Criterium - Clinical Trials - CRO

IVR/IWR & ePRO

Seamless interfacing with ancillary support technologies

Our Specialty Translational Research Oncology Consortia

Our Flagship Research Division, comprised of Top Universities in USA and Canada

GI Cancer Consortium

GI Cancer Consortium

Providing expertise and innovative solutions for the rapid design, implementation, management and completion of complex GI cancer trials.
Learn More

Myeloma Consortium

Myeloma Consortium

A full service research model that has combined expertise in carrying out the operational components of oncology clinical research.
Learn More

Breast Cancer Consortium

Breast Cancer Consortium

An innovative research model that has brought together an expert team of institutions and investigators to design clinical trials in breast cancer.
Learn More

Thoracic Oncology Consortium

Thoracic Oncology Consortium

Designing and rapidly completing clinical trials in thoracic and lung cancer with the ultimate goal of identifying new drugs to treat this disease.
Learn More

Genitourinary Cancer Consortium

Genitourinary Cancer Consortium

Expediting the process of identifying and efficiently testing active new compounds for the treatment of GU cancer.
Learn More

Therapeutic Areas

Our expertise covers a wide range of clinical indications:

Oncology

Allergy & Asthma

Dermatology

Orthopedics

...more

News & Publications

The Latest Research in Blood Disorders
New research and treatments for blood disorders have accelerated personalized care for the millions of patients living with the effects of these often serious conditions. From improved diagnostics to precision gene therapies, new technology and approaches to treatment are improving quality of life and delivering life-saving care faster.

Oncology Consortia News

Academic GI Cancer Consortium Multicenter Phase II Trial Published in The Oncologist
A collaborative study from the Academic GI Cancer Consortium (AGICC) has been published in The Oncologist, reporting results from a multicenter Phase II trial evaluating FOLFOXIRI plus panitumumab as first-line therapy for patients with left-sided, RAS wild-type metastatic colorectal cancer. The study demonstrated a 74% objective response rate, 96% disease control rate, and median progression-free survival of 17 months, with the authors reporting response and progression-free survival outcomes among the highest reported in stage IV colon cancer.